There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn´s disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.
|Translated title of the contribution
|Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn´s disease
|Number of pages
|Revista Chilena de Infectologia
|Published - Oct 2017
Bibliographical notePublisher Copyright:
© 2018, Sociedad Chilena de Infectologia. All rights reserved.